Réaction #334884

ord-74f19f2684e14a59a7a5c52e15c17844

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    Extractionwas extracted six times with ethyl acetate
  2. 2
    SéchageThe extract was dried with anhydrous magnesium sulfate
  3. 3
    Concentrationconcentrated
  4. 4
    workup.ADDITIONThere was added 250 ml of acetonitrile to the concentrated solution
  5. 5
    workup.ADDITIONwas added dropwise for 40 minutes
  6. 6
    workup.STIRRINGwhile vigorously stirring
  7. 7
    Températurewith heating
  8. 8
    Températureunder reflux
  9. 9
    TempératureAfter the solution was further heated
  10. 10
    Températureunder reflux for 1 hour
  11. 11
    Autrethe obtained reaction mixture
  12. 12
    Concentrationwas concentrated
  13. 13
    Autrefollowed by purification with 50 g of silica-gel column-chromatography (eluent; methylene chloride→diethyl ether)

Mode opératoire

There was dissolved 2.054 g (5.0 mmol) of 3-benzylamino-2-(1-hydroxyethyl)-5-trimethylsilyl-4-pentinic acid phenylthioester in 40 ml of THF, to which 3 ml of 4 N potassium hydroxide was added and the mixture was stirred at room temperature for 3 hours. The reaction mixture was neutralized with 2 N hydrochloric acid and was extracted six times with ethyl acetate while conducting salting-out. The extract was dried with anhydrous magnesium sulfate and concentrated. There was added 250 ml of acetonitrile to the concentrated solution, and then 1.57 g (60 mmol) of triphenylphosphine was added, to which 1.32 g (6.0 mmol) of 2,2'-dipyridyldisulfide in 50 ml of acetonitrile was added dropwise for 40 minutes while vigorously stirring with heating under reflux. After the solution was further heated under reflux for 1 hour, the obtained reaction mixture was concentrated, followed by purification with 50 g of silica-gel column-chromatography (eluent; methylene chloride→diethyl ether) and then with 50 g of silica-gel column-chromatography (eluent;hexane:diethyl ether=1:4) to give 801 mg of a trans-form and 62 mg of a cis-form of 1-benzyl-4-ethynyl-3-(1-hydroxyethyl)-2-azetidinone.

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US04709064uspto-grants-1987_11